tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

XLO Stock Latest News

Xilio Therapeutics Approves 2025 Stock Incentive Plan
Company AnnouncementsXilio Therapeutics Approves 2025 Stock Incentive Plan
5d ago
8K
XLO
Xilio Therapeutics Reports Revenue Growth Amidst Challenges
PremiumCompany Announcements
Xilio Therapeutics Reports Revenue Growth Amidst Challenges
13d ago
XLO
Xilio Therapeutics expects cash to fund operations into Q1 of 2027
PremiumThe Fly
Xilio Therapeutics expects cash to fund operations into Q1 of 2027
18d ago
XLO
Xilio Therapeutics reports Q3 EPS (11c) vs (22c) last year
PremiumThe Fly
Xilio Therapeutics reports Q3 EPS (11c) vs (22c) last year
18d ago
XLO
Xilio Therapeutics presents new data across portfolio at SITC
PremiumThe Fly
Xilio Therapeutics presents new data across portfolio at SITC
24d ago
XLO
Xilio Therapeutics announces new data on Phase 2 trial of vilastobart
PremiumThe FlyXilio Therapeutics announces new data on Phase 2 trial of vilastobart
24d ago
XLO
Xilio Therapeutics Transfers Listing to Nasdaq Capital Market
Premium
Company Announcements
Xilio Therapeutics Transfers Listing to Nasdaq Capital Market
2M ago
8K
XLO
Xilio Therapeutics Initiates Phase 2 Trial for XTX301
Premium
Company Announcements
Xilio Therapeutics Initiates Phase 2 Trial for XTX301
3M ago
8K
XLO
Xilio Therapeutics announces initiation of Phase 2 trial for efarindodekin alfa
PremiumThe Fly
Xilio Therapeutics announces initiation of Phase 2 trial for efarindodekin alfa
3M ago
XLO
GILD
Xilio Therapeutics sees cash runway into 1Q27
PremiumThe Fly
Xilio Therapeutics sees cash runway into 1Q27
3M ago
XLO
Xilio Therapeutics Faces Nasdaq Equity Compliance Challenge
PremiumCompany Announcements
Xilio Therapeutics Faces Nasdaq Equity Compliance Challenge
3M ago
8K
XLO
Xilio Therapeutics Reports Strong Pipeline Progress and Financial Results
PremiumCompany Announcements
Xilio Therapeutics Reports Strong Pipeline Progress and Financial Results
3M ago
XLO
Promising Future for Xilio Therapeutics: Strong Financial Position and Encouraging Trial Results Support Buy Rating
PremiumRatingsPromising Future for Xilio Therapeutics: Strong Financial Position and Encouraging Trial Results Support Buy Rating
4M ago
XLO
Xilio Therapeutics reports Q2 EPS (16c) vs (24c) last year
Premium
The Fly
Xilio Therapeutics reports Q2 EPS (16c) vs (24c) last year
4M ago
XLO
Snap downgraded, Leidos upgraded: Wall Street’s top analyst calls
Premium
The Fly
Snap downgraded, Leidos upgraded: Wall Street’s top analyst calls
4M ago
IT
ALC
Xilio Therapeutics initiated with an Outperform at Leerink
PremiumThe Fly
Xilio Therapeutics initiated with an Outperform at Leerink
4M ago
XLO
Xilio Therapeutics Expands Authorized Shares at Annual Meeting
PremiumCompany Announcements
Xilio Therapeutics Expands Authorized Shares at Annual Meeting
6M ago
8K
XLO
Xilio Therapeutics Expands Board with New Director
PremiumCompany Announcements
Xilio Therapeutics Expands Board with New Director
6M ago
8K
XLO
Xilio Therapeutics Announces $50M Public Offering
PremiumCompany Announcements
Xilio Therapeutics Announces $50M Public Offering
6M ago
8K
XLO
Xilio Therapeutics announces pricing of $50M public offering
PremiumThe FlyXilio Therapeutics announces pricing of $50M public offering
6M ago
XLO
Xilio Therapeutics Presents Phase 2 Trial Data Update
Premium
Company Announcements
Xilio Therapeutics Presents Phase 2 Trial Data Update
6M ago
8K
XLO
Xilio Therapeutics announces offering of warrants, no amount given
Premium
The Fly
Xilio Therapeutics announces offering of warrants, no amount given
6M ago
XLO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >